BIOMAT Database Logo BIOMAT Database Logo

Studies of metabolism and disposition of potent human immunodeficiency virus (HIV) integrase inhibitors using 19F-NMR spectroscopy. 2007

E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Department of Pharmacology, Istituto di Ricerche di Biologia Molecolare (IRBM) P. Angeletti, Merck Research Laboratories, Pomezia, Rome, Italy. edith_monteagudo@merck.com

(19)F-nuclear magnetic resonance (NMR) has been extensively used in a drug-discovery programme to support the selection of candidates for further development. Data on an early lead compound, N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(4-methylmorpholin-3-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide (compound A (+)), and MK-0518 (N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide), a potent inhibitor of this series currently in phase III clinical trials, are described. The metabolic fate and excretion balance of compound A (+) and MK-0518 were investigated in rats and dogs following intravenous and oral dosing using a combination of (19)F-NMR-monitored enzyme hydrolysis and solid-phase extraction chromatography and NMR spectroscopy (SPEC-NMR). Dosing with the (3)H-labelled compound A (+) enabled the comparison of standard radiochemical analysis with (19)F-NMR spectroscopy to obtain quantitative metabolism and excretion data. Both compounds were eliminated mainly by metabolism. The major metabolite identified in rat urine and bile and in dog urine was the 5-O-glucuronide.

UI MeSH Term Description Entries
D008297 Male Males
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D009930 Organic Chemicals A broad class of substances containing carbon and its derivatives. Many of these chemicals will frequently contain hydrogen with or without oxygen, nitrogen, sulfur, phosphorus, and other elements. They exist in either carbon chain or carbon ring form. Organic Chemical,Chemical, Organic,Chemicals, Organic
D011760 Pyrrolidinones A group of compounds that are derivatives of oxo-pyrrolidines. A member of this group is 2-oxo pyrrolidine, which is an intermediate in the manufacture of polyvinylpyrrolidone. (From Merck Index, 11th ed) Pyrrolidinone,Pyrrolidone,Pyrrolidones
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D005461 Fluorine A nonmetallic, diatomic gas that is a trace element and member of the halogen family. It is used in dentistry as fluoride (FLUORIDES) to prevent dental caries. Fluorine-19,Fluorine 19
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068898 Raltegravir Potassium A pyrrolidinone derivative and HIV INTEGRASE INHIBITOR that is used in combination with other ANTI-HIV AGENTS for the treatment of HIV INFECTION. Isentress,MK 0518,MK-0518,MK0518,Raltegravir,0518, MK,Potassium, Raltegravir
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001711 Biotransformation The chemical alteration of an exogenous substance by or in a biological system. The alteration may inactivate the compound or it may result in the production of an active metabolite of an inactive parent compound. The alterations may be divided into METABOLIC DETOXICATION, PHASE I and METABOLIC DETOXICATION, PHASE II.

Related Publications

E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Inhibitors of human immunodeficiency virus integrase.
March 1993, Proceedings of the National Academy of Sciences of the United States of America,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Inhibitors of human immunodeficiency virus integrase.
January 1999, Advances in virus research,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Studies on the metabolism of fluorinated xenobiotics in the rat using 19F-NMR and 1H-NMR spectroscopy.
January 1990, Journal of pharmaceutical and biomedical analysis,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase.
October 1996, Molecular pharmacology,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Highly potent synthetic polyamides, bisdistamycins, and lexitropsins as inhibitors of human immunodeficiency virus type 1 integrase.
August 1998, Molecular pharmacology,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Isolation of two highly potent and non-toxic inhibitors of human immunodeficiency virus type 1 (HIV-1) integrase from Salvia miltiorrhiza.
July 2002, Antiviral research,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Correction to Fragment-Linking Approach Using 19F NMR Spectroscopy To Obtain Highly Potent and Selective Inhibitors of β-Secretase.
April 2017, Journal of medicinal chemistry,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Dihydroxythiophenes are novel potent inhibitors of human immunodeficiency virus integrase with a diketo acid-like pharmacophore.
July 2006, Journal of virology,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
Beauvericin and enniatins H, I and MK1688 are new potent inhibitors of human immunodeficiency virus type-1 integrase.
December 2009, The Journal of antibiotics,
E Monteagudo, and S Pesci, and M Taliani, and F Fiore, and A Petrocchi, and E Nizi, and M Rowley, and R Laufer, and V Summa
19F NMR studies of enflurane elimination and metabolism.
January 1992, NMR in biomedicine,
Copied contents to your clipboard!